| Teva Pharma AG - Temozolomid-Teva 180 mg, Kapseln | | 61225 | | 05 | | Temozolomid-Teva 180 mg | | Kapseln | | L01AX03 | | Temozolomid | | 14.10.2010 | | |
| | Composition | | temozolomidum 180 mg, lactosum 150.48 mg, carboxymethylamylum natricum A corresp. natrium 0.756 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, kalii hydroxidum, E 172 (rubrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Ammonii Hydroxidum | | | Temozolomide | 180 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Temozolomide | 180 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Acidum Stearicum | | | | Acide Tartarique | | | | Carboxymethylamylum Natricum A | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactosum | 150.48 mg | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
